Skip to main content
  • Contact Us
  • Subscriber Sign In
Evaluate Logo

navigation

  • What We Do
    • Commercial Intelligence
    • Products
      • Evaluate Pharma
      • Evaluate Omnium
      • Evaluate Medtech
      • Evaluate Epi
      • Japan Drug Forecasts
      • Europe Drug Forecasts
      • CDMO Intelligence
    • Pharma Consulting & Analytics
      • Pharma Consulting & Analytics
      • Data Feeds
    • Evaluate Vantage
      • News
      • Analysis
      • Policy & Pricing
      • Insights
      • Events
      • Medtech
      • Therapy Areas
    • Evaluate for Biotech
  • How We Can Help You
    • Pharma and Biotech
    • Financial Services
    • Management Consultancies
    • Service Providers
    • Customer Testimonials
  • Thought Leadership
    • Multimedia
    • Blog
  • About Us
    • Press Releases
    • Media Coverage
    • Executive Team
    • Vision & History
  • Contact Us
  • Sign Up for Evaluate Vantage
  • Talent
  • Subscriber Sign In

 

Vantage logo

Vantage

  • News
    • Snippets
    • Deals
    • Trial results
    • Patents and litigation
    • Corporate strategy
  • Analysis
    • Interviews
    • Spotlight
    • Vantage points
    • Vantage views
  • Insights
    • M&A
    • IPO
    • NME approvals
    • Quarterly shareprice performance
    • Venture financing
    • Vantage data points
    • Other data
  • Events
    • Company events
    • Conferences
    • Upcoming events
  • Medtech
  • Therapy Areas

Breadcrumb

  1. Home
  2. Vantage
  3. Articles
  4. Insights
  5. Vantage Data Points
  6. Share Price Movers October 2019
Vantage Logo
November 04, 2019

Share price movers – October 2019

  • author
  • Edwin Elmhirst

Biggest share price movements - Oct 2019
Vantage Data Points

Related Companies

Achillion Pharmaceuticals
Assembly Biosciences
Botanix Pharmaceuticals
Constellation Pharmaceuticals
Cyclerion Therapeutics
Kiadis Pharma
Ra Pharmaceuticals
Reata Pharmaceuticals
ReNeuron Group
Savara Pharmaceuticals
Download PDF

Share This Article

 

Latest Reports

July 27, 2023

H1 Round Up: The haves and the have-nots

July 21, 2023

ADA/EASL eBook

View more...

Related Articles

Vantage logo
October 16, 2019

Alexion pays Achillion a $930m complement

Vantage logo
October 10, 2019

UCB goes to Ra for a complementary approach

Vantage logo
August 06, 2019

Share price movers – July 2019

Vantage logo
July 03, 2019

Share price catalysts: June 2019

Vantage logo
December 18, 2018

Achillion’s first oral Soliris rival hits the buffers

Open modal

Evaluate Logo

Evaluate HQ
44-(0)20-7377-0800

Evaluate Americas
+1-617-573-9450

Evaluate APAC
+81-80-1164-4754

Footer menu

  • Terms and conditions
  • Privacy Policies
  • Cookie Policy
  • Modern Slavery Statement

© Copyright 2023 Evaluate Ltd.

Sign up